Cosette Pharmaceuticals

JOBS

IN THE PRESS

Press Releases

Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market

July 10, 2024

·

2 min read

Pharm Country

Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of RECTIV® (nitroglycerin) ointment, 0.4%, with 180 days Competitive Generic Therapy (CGT) exclusivity

February 22, 2024

·

2 min read

Deals

Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.

January 3, 2024

·

3 min read

Pharm Country

Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million

December 20, 2023

·

5 min read

Pharm Country

Cosette Pharmaceuticals Partners With Mark Cuban Cost Plus Drug Company to Make CLOMID® More Affordable

October 3, 2023

·

5 min read

FDA

Cosette Pharmaceuticals Launches Metronidazole Vaginal Gel 0.75%, AB-rated to MetroGel-Vaginal® 0.75%

July 27, 2023

·

2 min read

Pharm Country

Cosette Pharmaceuticals Launches Dapsone 5% Gel, AB-Rated to Aczone® 5%

July 13, 2023

·

2 min read

Deals

Cosette Pharmaceuticals Acquires Intrarosa® from Endoceutics, Inc.

June 8, 2023

·

2 min read

Pharm Country

Cosette Pharmaceuticals Launches Betaine Anhydrous Powder, AB-rated to Cystadane® (betaine anhydrous for oral solution)

March 2, 2023

·

2 min read

FDA

Cosette Pharmaceuticals Announces the Approval and Launch of Metronidazole Gel USP, 1%

February 9, 2023

·

2 min read